Stay updated on Long-Term Upadacitinib in Crohn's Disease Clinical Trial
Sign up to get notified when there's something new on the Long-Term Upadacitinib in Crohn's Disease Clinical Trial page.

Latest updates to the Long-Term Upadacitinib in Crohn's Disease Clinical Trial page
- Check3 days agoChange DetectedThe site’s footer revision label was updated from v3.7.2 to v3.8.0 while the page continued to show a 403 error.SummaryDifference0.2%

- Check10 days agoChange DetectedA general NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the ClinicalTrials.gov interface, replacing the prior 403 error screen. The study details themselves are not shown.SummaryDifference2%

- Check17 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check24 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1; the page remains a 403 error screen.SummaryDifference0.2%

- Check45 days agoChange DetectedThe study record URL now serves a 403 Forbidden page, indicating access to the content is blocked; the error page includes the site header and navigation.SummaryDifference20%

- Check66 days agoChange DetectedAdded funding disclosure: 2015 ( U.S. NIH Grant/Contract ) under Other Study ID Numbers. Updated the page revision from v3.6.5 to v3.6.6 to reflect the current version.SummaryDifference0.1%

Stay in the know with updates to Long-Term Upadacitinib in Crohn's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Upadacitinib in Crohn's Disease Clinical Trial page.